Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study-Reference-Cited by-同舟云学术

Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study

Published:2020-03 Issue:1 Volume:8 Page:34-40
ISSN:2287-8882
Container-title:Prostate International
language:en
Short-container-title:Prostate International

Author:

King Liam,Christie David^ORCID,Arora Devinder,Anoopkumar-Dukie Shailendra

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Prostate Cancer in Australia. Cancer Series 79;Autstralian Institute of Health and Welfare,2013

3. Australian Cancer Incidence and Mortality (ACIM) books: Prostate Cancer 2016;Australian Institute of Health and Welfare,2016

4. Gleason grade progression is uncommon;Penney;Cancer Res,2013

5. Cancer in Australia;Autstralian Institute of Health and Welfare,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2/PGE2/JAK2/STAT3/MMP pathway;International Journal of Radiation Biology;2024-03-05

2. COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers;Medical Oncology;2024-01-02

3. Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer;PLOS ONE;2022-05-20

4. A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment;Frontiers in Pharmacology;2022-03-11

5. Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics;Pharmacology & Therapeutics;2021-12